Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-GBM Disease”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Early research (Phase 1)Study completedNCT00002753
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 6
Early research (Phase 1)Study completedNCT00509431
What this trial is testing

Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 19
Testing effectiveness (Phase 2)Looking for participantsNCT05941507
What this trial is testing

Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
LigaChem Biosciences, Inc. 300
Large-scale testing (Phase 3)Ended earlyNCT00615186
What this trial is testing

Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy

Who this might be right for
Glioblastoma Multiforme
Bradmer Pharmaceuticals Inc. 9
Early research (Phase 1)Study completedNCT01183663
What this trial is testing

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 180
Very early researchActive Not RecruitingNCT04656535
What this trial is testing

AB154 Combined With AB122 for Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Yale University 46
Very early researchEnded earlyNCT04825275
What this trial is testing

Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioblastoma Multiforme of Brain+1 more
Milton S. Hershey Medical Center 7
Testing effectiveness (Phase 2)Looking for participantsNCT04094610
What this trial is testing

Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid TumorsLymphoma+1 more
Turning Point Therapeutics, Inc. 75
Testing effectiveness (Phase 2)Study completedNCT03157037
What this trial is testing

Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease

Who this might be right for
Anti-Glomerular Basement Membrane Antibody Disease
Mårten Segelmark 15
Early research (Phase 1)Study completedNCT02658981
What this trial is testing

Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)

Who this might be right for
GlioblastomaGliosarcomaRecurrent Brain Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 63
Not applicableStudy completedNCT03635385
What this trial is testing

Comparison of ANCA and Anti-GBM Auto-antibodies Removal Kinetics Between Plasma Exchanges and Immunoadsorption in Patients With ANCA-associated Vasculitis or Anti-GBM Disease

Who this might be right for
Kidney Failure, Acute
Assistance Publique Hopitaux De Marseille 40
Very early researchEnded earlyNCT04869449
What this trial is testing

Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioblastoma Multiforme of Brain+1 more
Milton S. Hershey Medical Center 1
Testing effectiveness (Phase 2)WithdrawnNCT02521090
What this trial is testing

EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma

Who this might be right for
Adult Brain GlioblastomaAdult GliosarcomaRecurrent Brain Neoplasm
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT01454596
What this trial is testing

CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII

Who this might be right for
Malignant GliomaGlioblastomaBrain Cancer+1 more
National Cancer Institute (NCI) 18
Not applicableUnknownNCT03801135
What this trial is testing

Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation

Who this might be right for
Humoral RejectionGuillain-Barre SyndromeMiller Fisher Syndrome+3 more
University Medical Centre Ljubljana 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06607016
What this trial is testing

A Clinical Trial With KJ103 in Anti-GBM Disease

Who this might be right for
Anti-Glomerular Basement Membrane Disease
Shanghai Bao Pharmaceuticals Co., Ltd. 12
Testing effectiveness (Phase 2)Ended earlyNCT01582152
What this trial is testing

Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma

Who this might be right for
Brain NeoplasmsCentral Nervous System Neoplasms
M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)Ended earlyNCT05275478
What this trial is testing

Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

Who this might be right for
Locally Advanced Solid Tumor
Tango Therapeutics, Inc. 110
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT02798406
What this trial is testing

Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects

Who this might be right for
Brain CancerBrain NeoplasmGlioma+8 more
DNAtrix, Inc. 49
Load More Results